Lantern Pharma Inc.LTRNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-21M

-30.2% YoY

Free Cash Flow

$-18M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	-0	0
Operating Income	-6	-13↓113.1%	-14↓14.6%	-18↓23.9%	-22↓24.3%
Net Income	-6	-12↓109.3%	-14↓15.3%	-16↓11.9%	-21↓30.2%
EBITDA	-6	-13↓113.1%	-14↓14.6%	-16↓9.5%	-22↓40.6%
EPS Diluted	-0.95	-1.13↓18.9%	-1.31↓15.9%	-1.47↓12.2%	-1930.92↓131255.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	19	52↑167.9%	37↓27.8%	22↓41.0%	8↓65.8%
Total Current Assets	20	73↑259.3%	59↓19.2%	43↓26.2%	25↓41.7%
Total Assets	20	74↑263.2%	59↓20.4%	44↓25.8%	26↓41.4%
Total Current Liabilities	1	2↑321.1%	3↑20.3%	3↓4.3%	4↑61.7%
Total Liabilities	1	2↑260.0%	3↑17.6%	3↓2.1%	4↑60.0%
Total Equity	20	72↑263.3%	56↓21.7%	41↓27.0%	21↓48.2%
Total Debt	0	0↑88.9%	0↓74.2%	0↑343.3%	0↑3.9%
Net Debt	-19	-51↓168.4%	-37↑27.6%	-22↑41.6%	-7↑66.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-6	-11↓87.4%	-13↓20.5%	-14↓12.4%	-18↓24.2%
Capital Expenditure	-0	-0↑4.0%	-0↓79.7%	-0↑32.7%	-0↑32.7%
Free Cash Flow	-6	-11↓87.1%	-13↓20.6%	-14↓12.3%	-18↓24.1%
Stock-Based Comp	1	1↓19.3%	1↑23.5%	1↓10.1%	0
Net Change in Cash	18	33↑85.0%	-15↓144.4%	-16↓6.9%	-14↑8.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance